Xiaotong Li

2 ta ish

AbbVie (United States)

1. Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine

   Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo +15

   MaqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.244235

2. Antitumor and immunomodulation activities of polysaccharide from Phellinus baumii

   Mingming Liu, Peng Zeng, Xiaotong Li +1

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.596506